Novavax Announces Closing of Public Offering

Resorbable Dextenza is the First Intracanalicular Insert for Drug Delivery

Patients with MS Suffered Stroke, Blood Vessel Tearing in Head and Neck After Receiving Drug

First Biosimilar For Adults With CD20-Positive, B-Cell Non-Hodgkin’s Lymphoma

Life-Threatening Side Effect of Drug for Acute Myeloid Leukemia

First Drug for Rare Autoimmune Disorder That Affects Nerve, Muscles Connection

Hope For Patients With Highly Aggressive Form of AML

Oncology Therapy for Adult and Pediatric Tumors With a Neurotrophic Receptor Tyrosine Kinase (NTRK) Gene Fusion

First Hedgehog Pathway Inhibitor Approved for AML in Adults Aged 75 and Older

Gene Therapy Granted Regenerative Medicine, Fast Track Designations